These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28355395)

  • 1. Obesity and kidney disease.
    Silva Junior GB; Bentes AC; Daher EF; Matos SM
    J Bras Nefrol; 2017 Mar; 39(1):65-69. PubMed ID: 28355395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight, obesity and metabolic alterations in chronic kidney disease.
    Zoccali C
    Prilozi; 2009 Dec; 30(2):17-31. PubMed ID: 20087247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adipose tissue as an endocrine organ.
    Adamczak M; Wiecek A
    Semin Nephrol; 2013 Jan; 33(1):2-13. PubMed ID: 23374889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and chronic kidney disease.
    Kopple JD
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S29-30. PubMed ID: 20797567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-related kidney disease.
    Snyder S; Turner GA; Turner A
    Prim Care; 2014 Dec; 41(4):875-93. PubMed ID: 25439539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney disease in the obese patient.
    Naguib MT
    South Med J; 2014 Aug; 107(8):481-5. PubMed ID: 25084184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of obesity on chronic kidney disease.
    Kopple JD; Feroze U
    J Ren Nutr; 2011 Jan; 21(1):66-71. PubMed ID: 21195923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines as a link between obesity and chronic kidney disease.
    Briffa JF; McAinch AJ; Poronnik P; Hryciw DH
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1629-36. PubMed ID: 24107418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease.
    de Vries AP; Ruggenenti P; Ruan XZ; Praga M; Cruzado JM; Bajema IM; D'Agati VD; Lamb HJ; Pongrac Barlovic D; Hojs R; Abbate M; Rodriquez R; Mogensen CE; Porrini E;
    Lancet Diabetes Endocrinol; 2014 May; 2(5):417-26. PubMed ID: 24795255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'.
    Kincaid-Smith P
    J Hypertens; 2004 Jun; 22(6):1051-5. PubMed ID: 15167435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and CKD progression: hard facts on fat CKD patients.
    Mallamaci F; Tripepi G
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv105-8. PubMed ID: 24179007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.
    Tesauro M; Canale MP; Rodia G; Di Daniele N; Lauro D; Scuteri A; Cardillo C
    Cardiol Res Pract; 2011 Mar; 2011():653182. PubMed ID: 21403882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scope and mechanisms of obesity-related renal disease.
    Hunley TE; Ma LJ; Kon V
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):227-34. PubMed ID: 20134323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.